sahinozgur – Page 3 – OZGUR SAHIN LAB

News From #AACR23

By sahinozgur, 3 yearsApril 18, 2023 ago

Our new paper is published in Cell Death & Differentiation

Our latest article has been published in Cell Death & Differentiation. The study focuses on the molecular mechanism of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) in highly aggressive breast tumors with Centrosome amplification (CA). We demonstrated, for the first time, that TACC3 forms distinct functional interactomes regulating different processes Read more

By sahinozgur, 3 yearsMarch 2, 2023 ago

Announcement

A new postdoctoral fellowship position is available!

Postdoctoral Fellow position to contribute to cancer biology research at the intersection of drug resistance, metastasis, and drug discovery in breast cancer. The Sahin Lab in the Department of Biochemistry and Molecular Biology & Hollings Cancer Center at Medical University of South Carolina (MUSC) in Charleston, South Carolina invites applications Read more

By sahinozgur, 3 yearsJanuary 19, 2023 ago

Announcement

A new postdoctoral fellow position at the intersection of drug resistance, metastasis and drug discovery is available at The Sahin Lab at MUSC Hollings Cancer Center

Link is here: https://www.nature.com/naturecareers/job/postdoctoral-scholar-biochemistry-and-molecular-biology-medical-university-of-south-carolina-musc-761242

By sahinozgur, 3 yearsJuly 18, 2022 ago

News

Our Lab moved to the Department of Biochemistry & Molecular Biology and Hollings Cancer Center at MUSC!

Dr. Sahin has recently accepted a Professor and SmartState Endowed Chair position at the Dept. of Biochemistry & Molecular Biology and Hollings Cancer Center at Medical University of South Carolina. Starting May 1, our lab is located at HO703 at Hollings Cancer Center.

By sahinozgur, 3 yearsMay 4, 2022 ago

Grant

Our new R01 grant is funded by the NIH/NCI

This 5-year grant will address the mechanisms of resistance to chemotherapy in highly aggressive breast cancers using cutting-edge methodologies, including testing our recently developed LOX inhibitors. NEW positions are available for highly motivated postdocs and graduate students.

By sahinozgur, 4 yearsDecember 19, 2021 ago

Grant

Dr. Sahin receives highly prestigious Mary Kay Ash Foundation grant

This work aims to enhance the efficacy of antibody-drug conjugate (ADC) therapy in aggressive breast cancer. Here is the press release: https://marykayashfoundation.org/what-we-do/cancer-research/grant-recipients/

By sahinozgur, 4 yearsDecember 3, 2021 ago

Announcement

A NEW postdoc position is immediately available in our lab

If you are interested in working at the intersection of mechanisms of drug resistance, metastasis and drug discovery, please apply via: https://www.nature.com/naturecareers/job/postdoctoral-fellow-in-cancer-research-university-of-south-carolina-columbia-sc-746191

By sahinozgur, 4 yearsAugust 12, 2021 ago

Grant

Our R01 grant is funded by the NIH/NCI

Our R01 grant aiming at blocking tumor growth and metastasis in highly aggressive breast cancers has been funded. In this exciting project, we will target highly aggressive breast cancers with our newly developed inhibitor.

By sahinozgur, 4 yearsAugust 12, 2021 ago

Announcement

A postdoctoral research fellow position is immediately available in our lab

Details of the position and how to apply are here.

By sahinozgur, 4 yearsMay 3, 2021 ago